Ever expanding rapid diagnostic products

Inverness Medical Innovations develops and manufactures rapid diagnostic products for use in preventive as well as interventional therapies.

Photo: Ever expanding rapid diagnostic products

Information from patients’ body fluids, or tissue, assists physicians to diagnose disease, as well as to measure a patient’s response to a specific therapy. Its range of clinical diagnostic products already includes, the well-known brands Clearview, Inverness Medical TestPack, Binax, Determine, BioStar, and many others. ‘Our high quality immunoassays in pregnancy testing and fertility, respiratory, enteric and infectious diseases, autoimmune disorders, osteoporosis, cancer and cardiology, have demonstrated proven efficiency in clinics, hospitals and laboratories internationally,’ the firm points out.

Currently, Inverness Medical Innovations reports that it is exploring opportunities to optimise the use of its technologies, as well as continually evaluating other technological advances, for development or acquisition, in a variety of medical/health areas.

14.11.2006

More on the subject:

Related articles

Photo

News • Stain-Free Histology

Nanophotonic slides add color to tissue samples

Researchers have developed a method to enhance the cellular features in pathology slides based on “structural color” – the same effect that gives peacock feathers their unique sheen.

Photo

News • Neuroprotective antiviral state in the CNS

Remarkable early warning system helps the brain prepare for a viral attack

Virus-associated molecules in the foot are enough to trigger the network: Research reveals a remarkable mechanism, in which the brain prepares for a potential viral attack within hours of infection.

Photo

News • Fluorescence lifetime imaging microscopy

New technique could aid targeted lung cancer treatment

Detecting genetic mutations associated with lung cancer via laboratory tests can be expensive and time-consuming, and use up valuable tissue from small biopsy samples. A new approach aims to fix this.

Subscribe to Newsletter